Search Results 21-30 of 17335 for Teratogenic

1. Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study - Mayo Clinic

   genotoxic, mutagenic and teratogenic effects. - Women of childbearing potential must have a negative pregnancy test ≤ 14 days prior to registration ...

2. Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients - Mayo Clinic

   An agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant persons;; Nursing persons. Received chemotherapy or radiation within the prior ...

3. A Study to Evaluate CB-839 With Radiation Therapy and Temozolomide in Treating Participants With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma - Mayo Clinic

   For this reason and because alkylating agents as well as TMZ are known to be teratogenic, women of child-bearing potential and men must agree to use ...

4. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

   ... teratogenic effects on the developing fetus and newborn are unknown, and topotecan, an agent that has known genotoxic, mutagenic and teratogenic effects:.

5. PKCι & mTOR Inhibition With Auranofin+Sirolimus for Squamous Cell Lung Cancer - Mayo Clinic

   Any of the following because this study involves an agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant women; Nursing women; Men or ...

6. Trial Using Keytruda as Initial Therapy in the Treatment of Advanced Mycosis Fungoides - Mayo Clinic

   an agent that has known genotoxic, mutagenic and teratogenic effects: Pregnant women;; Nursing women;; Men or women of childbearing potential who are ...

7. Neonatally-Derived Tissues for Biotherapeutic Manufacturing - Mayo Clinic

   About this study. The purpose of this study is to create a shared Mayo Clinic resource for biotherapies derived from various perinatal tissues (umbilical ...

8. Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients - Mayo Clinic

   ... teratogenic potential of the therapy utilized in this trial. Appropriate methods of birth control include abstinence, oral contraceptives, implantable ...

9. Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorder - Mayo Clinic

   ... teratogenic adverse events as seen in animal/human studies, or because there is currently no available information regarding human fetal or teratogenic ...

10. A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT - Mayo Clinic

    - Female patients who are pregnant, since fetal toxicities and teratogenic effects have been noted for several of the study drugs. - Note: Serum and urine ...